Status:
COMPLETED
Strengthening the Healthy Adult Mode: a Case Experimental Study Exploring the Effects of a New Schema Therapy Protocol in an Adult Outpatient Population.
Lead Sponsor:
Zuyderland Medisch Centrum
Conditions:
Trauma, Psychological
Personality Disorders
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Background: Strengthening the Healthy Adult schema mode is the ultimate goal in Schema Therapy, working as an assumed mechanism of long-term change through improved positive mental health. Evidence-ba...
Detailed Description
Schema therapy (ST; Young, 1990, Young et al., 2003) is an effective treatment for personality disorders and other chronic psychopathology, leading to significant improvement in functioning in most pa...
Eligibility Criteria
Inclusion
- age of 18 to 65 year
- a diagnosis of personality disorder and/or (comorbid) persistent mood-/somatic symptom disorder according to DSM-5 at the start of regular group or individual ST;
- following final stage individual or group ST (as indicated by the patients' certified Schema Therapist). If ST is terminated, this must be within four months before starting with current ST-HA study;
- suboptimal positive mental health as indicated by low to moderate levels of well-being, determined by the Mental Health Continuum
- Short Form (MHC-SF; Keyes, 2002; Lamers et al., 2011) or below average to low scores on the Positive Affect scale of the Positive And Negative Affect Schedule (PANAS; Watson et al., 1988);
- self-reported motivation for a 10-session psychological intervention focusing on positive mental health;
- have access to a computer or tablet with a good Internet connection;
- possess an e-mail address;
- have sufficient proficiency of the Dutch language (reading and writing);
- provided informed consent.
Exclusion
- severe psychiatric disorders: acute suicidal risk, a psychotic and/or bipolar disorder, schizophrenia, delirium, dementia of severe cognitive impairment;
- ongoing other ST/psychological treatment during the baseline and treatment phase;
- former treatment based on the ST-HA protocol.
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 25 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04466163
Start Date
September 1 2020
End Date
January 25 2022
Last Update
January 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zuyderland MC
Sittard, Limburg, Netherlands, 6162BG